Fitbit Alta HR heart-rate rise leads to vasculitis diagnosis

AI system

System: Fitbit Alta HR resting heart rate (Fitbit app)
Model: Not assessed
Release: Exact release not established.
Application developer: Fitbit (Google)
Role: The device calculated resting heart rate over time.
Configuration: The participant used a Fitbit Alta HR.
Inputs and outputs: Not assessed
Autonomy: Not assessed
Workflow: The wearer tracks resting heart rate over months with a Fitbit. A systemic inflammatory illness raises resting heart rate persistently. The wearer brings the trend to a clinician who pursues imaging.
Human oversight: Not assessed
Relation to AI: The device's resting-heart-rate algorithm produced the trend the patient noticed; there was no alert, and the patient and clinicians drew the inference. The authors credit the elevated resting heart rate with an earlier diagnosis.
AI contribution: The device's resting-heart-rate algorithm produced the trend the patient noticed; there was no alert, and the patient and clinicians drew the inference. The authors credit the elevated resting heart rate with an earlier diagnosis.

Benefits

Outcome identifiers: Not assessed
Benefit: resting heart rate had risen persistently from about 55 to about 75 beats per minute
Category: Improved Physical Health
Status: Not assessed
Beneficiary groups: People.
Beneficiaries: Not assessed
Reach: Not assessed
Distribution and access: Not assessed
Duration: Not assessed
Expected?: No
Costs and harms: Not assessed

Measurement

Studies: Not assessed
Study design: Not assessed
Measurement: Not assessed
Setting and sample: Not assessed
Measures: resting heart rate had risen persistently from about 55 to about 75 beats per minute
Comparison: Not assessed
Results: resting heart rate had risen persistently from about 55 to about 75 beats per minute
Additional value from AI: Not assessed
Limitations: Not assessed
Denominators: Not assessed
Materials for replication: Not assessed

Money

Kind of value: Not assessed
Amount: Not assessed
Currency and prices: Not assessed
Period and unit: Not assessed
Realization: Not assessed
Recipients and payers: Not assessed
Gross or net: Not assessed
Included costs: Not assessed
Comparison: Not assessed
Method: Not assessed
Return and payback: Not assessed

People and places

Participants: Developer: Fitbit (Google).
Jurisdictions: Benefit: Zurich, Switzerland. Developer: United States.
Ownership and control: Not assessed
Dependencies: Not assessed
Cross-border connections: Not assessed
Geopolitical implications: Not assessed

Follow-up

Conditions for replication: A stable personal baseline exists. The clinician treats the trend as a signal rather than noise. Diagnostic imaging and immunosuppressive therapy are available.
Replication attempts: Not assessed
Later findings: Both cited entries are the same case report; no later development was found.
Availability: Not assessed
Institutional decision: Not assessed
Grounds: Not assessed
Action and result: Not assessed
Success criterion: Not assessed

Evidence

Source numbers: AIBD-0027-source-0001–0002
Citations: Numbered references below.
Language: Not assessed
Source relationships: Independent
Original evidence: Not assessed
Access and versions: Not assessed
Supported findings: Not assessed
Evidence links: Not assessed
Evidence strength: Not assessed
Missing evidence: Not assessed

Grades

Assessed benefits: People.
Depth: People: 2.
Reasons: People: One woman obtained an earlier diagnosis of giant cell arteritis with large vessel involvement and prompt immunosuppressive treatment that resolved her symptoms. A material benefit to one person.
Observed or intended: Not assessed
Rubric: Not assessed
Assessor and date: Not assessed
Alternative assessments: Not assessed
Fill: Independently studied

Entry details

Kind

Not assessed

Related entries

Consumer wearable health metric read in its app: a Fitbit resting-heart-rate trend proved true, while Oura's inferred sleep stages were allegedly less accurate than marketed, harming ring purchasers who relied on them.

Field

Healthcare (rheumatology). Consumer wearables.

Purpose

The Fitbit Alta HR computes resting heart rate for fitness tracking; it was not built to detect vasculitis, so this benefit was not its purpose.

Dates

Date basis unassessed: 2022 (precision unassessed). Updated: 21 October 2026.

Stage

Not assessed

Version

SHA-256: eeda0aac83a8…

References

Other identifiers: AI Incident Database: 1666.
Category mappings: Not assessed
Brief: Not assessed
Revisions: 5 revisions. Latest: 21 October 2026.

Sources

Case report Independent author

Gkikopoulos N, Wenger M, Distler O, Becker M (2022). Self-monitoring of the resting heart rate using a fitness tracker smartwatch application leads to an early diagnosis of large vessel vasculitis. BMJ Case Reports 15(2):e245021.
Case report Independent author

Gkikopoulos N et al. (2022). BMJ Case Reports 15(2):e245021.